We found most CD8+ T and NK subtypes are enriched in non-tumor livers and depleted in primary and metastatic tumors (Fig. 2a), distinct from the tissue preferences of T cells in breast9 or lung cancer10. The gene discussed is CD8A; the disease is neoplasm.